News ID: 272316
Published: 0158 GMT August 01, 2020

Russia preparing mass vaccination against coronavirus for October

Russia preparing mass vaccination against coronavirus for October
BLOOMBERG

Russia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported on Saturday, after a vaccine completed clinical trials.

Health Minister Mikhail Murashko said the Gamaleya Institute, a state research facility in Moscow, had completed clinical trials of the vaccine and paperwork is being prepared to register it, Interfax news agency reported.

He said doctors and teachers would be the first to be vaccinated.

"We plan wider vaccinations for October," Murashko was quoted as saying.

A source told Reuters this week that Russia's first potential COVID-19 vaccine would secure local regulatory approval in August and be administered to health workers soon thereafter.

The Gamaleya Institute has been working on an adenovirus-based vaccine.

At a Wednesday meeting chaired by President Vladimir Putin, Deputy Prime Minister Tatyana Golikova singled out two vaccines under development.

Production of the first, which is being tested by Gamaleya and the Defense Ministry, is set for September, Golikova said.

Another vaccine being developed by the Vektor State laboratory near the Siberian city of Novosibirsk should be launched in October, she added.

Russia, which has the world’s fourth-largest coronavirus caseload, hopes to be the first country to produce a vaccine.

Russian President Vladimir Putin has said it is important to achieve a finished product in a “careful and balanced way.”

“One should be absolutely certain in a vaccine,” he said.

On Saturday, Russia reported 95 additional deaths from the novel coronavirus, taking its total to 14,058.

Officials reported 5,462 new cases, raising the total to 845,443.

More than 100 possible vaccines are being developed around the world to try to stop the COVID-19 pandemic.

At least four are in final Phase III human trials, according to World Health Organization (WHO) data, including three developed in China and another in Britain.

 

   
KeyWords
 
Comments
Comment
Name:
Email:
Comment:
Security Key:
Captcha refresh
Page Generated in 0/1364 sec